Physiological 18F-FDG uptake in the ovaries and uterus of healthy female volunteers

  • Sadahiko Nishizawa
  • Masayuki Inubushi
  • Hiroyuki Okada
Original Article
First Online:
Received:
Accepted:

Abstract

Purpose

Good knowledge of physiological 18F-fluorodeoxglucose (18F-FDG) uptake in the healthy population is of great importance for the correct interpretation of 18F-FDG positron emission tomography (PET) images of pathological processes. The purpose of this study was to investigate the physiological 18F-FDG uptake in the ovaries and uterus of healthy female volunteers.

Methods

One hundred and 33 healthy females, 78 of whom were premenopausal (age 37.2±6.9 years) and 55 postmenopausal (age 55.0±2.7 years), were examined using whole-body 18F-FDG PET and pelvic magnetic resonance (MR) imaging. Focal 18F-FDG uptake in the ovaries and uterus was evaluated visually and using standardised uptake value (SUVs). Anatomical and morphological information was obtained from MR images.

Results

Distinct ovarian 18F-FDG uptake with an SUV of 3.9±0.7 was observed in 26 premenopausal women out of 32 examined during the late follicular to early luteal phase of the menstrual cycle. Eighteen of the 32 women also showed focal 18F-FDG uptake in the endometrium, with an SUV of 3.3±0.3. On the other hand, all nine women in the first 3 days of the menstrual cycle demonstrated intense 18F-FDG uptake in the endometrium, with an SUV of 4.6±1.0. No physiological 18F-FDG uptake was observed in the ovaries or uterus of any postmenopausal women.

Conclusion

In women of reproductive age, 18F-FDG imaging should preferably be done within a week before or a few days after the menstrual flow phase to avoid any misinterpretation of pelvic 18F-FDG PET images.

Keywords

FDG PET Ovary Uterus Physiological uptake 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Cook GJ, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med 1996;26:308–14.PubMedGoogle Scholar
  2. 2.
    Gordon BA, Flanagan FL, Dehdashti F. Whole-body positron emission tomography: normal variations, pitfalls, and technical considerations. AJR 1997;169:1675–80.PubMedGoogle Scholar
  3. 3.
    Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999;19:61–77.PubMedGoogle Scholar
  4. 4.
    Yasuda S, Ide M, Takagi S, Shohtsu A. Intrauterine accumulation of F-18 FDG during menstruation. Clin Nucl Med 1997;22:793–4.CrossRefPubMedGoogle Scholar
  5. 5.
    Chander S, Meltzer CC, McCook BM. Physiologic uterine uptake of FDG during menstruation demonstrated with serial combined positron emission tomography and computed tomography. Clin Nucl Med 2002;27:22–4.CrossRefPubMedGoogle Scholar
  6. 6.
    Lerman H, Metser U, Grisaru D, Fishman A, Kievshitz G, Even-Sapir E. Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT. J Nucl Med 2004;45:266–71.PubMedGoogle Scholar
  7. 7.
    Watanabe M, Shimizu K, Omura T, Sato N, Takahashi M, Kosugi T et al. A high-throughput whole-body PET scanner using flat panel PS-PMTs. IEEE Trans Nucl Sci 2004;51:796–800.CrossRefGoogle Scholar
  8. 8.
    Tanaka E, Kudo H. Subset-dependent relaxation in block-iterative algorithms for image reconstruction in emission tomography. Phys Med Biol 2003;48:1405–22.CrossRefPubMedGoogle Scholar
  9. 9.
    Outwater EK, Mitchell DG. Normal ovaries and functional cysts: MR appearance. Radiology 1996;198:397–402.PubMedGoogle Scholar
  10. 10.
    Togashi K. MR imaging of the ovaries: normal appearance and benign disease. Radiol Clin North Am 2003;41:799–811.PubMedGoogle Scholar
  11. 11.
    Espey LL. Ovulation as an inflammatory reaction—a hypothesis. Biol Reprod 1980;22:73–106.PubMedGoogle Scholar
  12. 12.
    Kol S, Ben-Shlomo I, Ruutiainen K, Ando M, Davies-Hill TM, Rohan RM, et al. The midcycle increase in ovarian glucose uptake is associated with enhanced expression of glucose transporter 3. J Clin Invest 1997;99:2274–83.PubMedGoogle Scholar
  13. 13.
    Vanatier D, Dufour P, Tordjeman-Rizzi N, Prolongeau JF, Depret-Moser S, Monnier JC. Immunological aspects of ovarian function: role of the cytokines. Eur J Obstet Gynecol Reprod Biol 1995;63:155–68.CrossRefPubMedGoogle Scholar
  14. 14.
    Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33:1972–80.PubMedGoogle Scholar
  15. 15.
    Flint APF, Denton RM. Glucose metabolism in the superovulated rat ovary in vitro. Effects of luteinizing hormone and the role of glucose metabolism in steroidogenesis. Biochem J 1969;112:243–54.PubMedGoogle Scholar
  16. 16.
    Chase CC Jr, Del Vecchio RP, Smith SB, Randel RD. In vitro metabolism of glucose by bovine reproductive tissues obtained during the estrous cycle and after calving. J Anim Sci 1992;70:1496–1508.PubMedGoogle Scholar
  17. 17.
    Gull I, Geva E, Lerner-Geva L, Lessing JB, Wolman I, Amit A. Anaerobic glycolysis. The metabolism of the preovulatory human oocyte. Eur J Obstet Gynecol Reprod Biol 1999;85:225–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Kunz G, Leyendecker G. Uterine peristaltic activity during the menstrual cycle: characterization, regulation, function and dysfunction. Reprod Biomed Online 2002;4 Suppl 2:5–9.PubMedGoogle Scholar
  19. 19.
    Fujiwara T, Togashi K, Yamaoka T, Nakai A, Kido A, Nishio S, et al. Kinematics of the uterus: cine mode MR imaging. Radiographics 2004;24:e19.PubMedGoogle Scholar
  20. 20.
    Nakai A, Togashi K, Yamaoka T, Fujiwara T, Ueda H, Koyama T, et al. Uterine peristalsis shown on cine MR imaging using ultrafast sequence. J Magn Reson Imaging 2003;18:726–33.CrossRefPubMedGoogle Scholar
  21. 21.
    Holder WD Jr, White RL Jr, Zugar JH, Easton EJ Jr, Greene FL. Effectiveness of positron emission tomography for the detection of melanoma metastases. Ann Surg 1998;227:764–9.CrossRefPubMedGoogle Scholar
  22. 22.
    Kao CH. FDG uptake in a huge uterine myoma. Clin Nucl Med 2003;28:249.CrossRefPubMedGoogle Scholar
  23. 23.
    Fenchel S, Grab D, Nuessle K, Kotzerke J, Reiber A, Kreienberg R, et al. Asymptomatic adnexal masses: correlation of FDG PET and histopathologic findings. Radiology 2002;223:780–8.PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Sadahiko Nishizawa
    • 1
  • Masayuki Inubushi
    • 1
  • Hiroyuki Okada
    • 1
  1. 1.Hamamatsu Medical Imaging CenterHamamatsu Medical Photonics FoundationHamakitaJapan

Personalised recommendations